29 January 2021
COVID-19 Fraud: An Emerging Risk For Companies - Will Hayes, Nicola Finnerty, Will Christopher & Eugenie Freeman write for PLC Magazine
Will Hayes, Nicola Finnerty, Will Christopher & Eugenie Freeman have written for PLC magazine considering liability for fraud relating to COVID-19 and how companies should respond to this emerging risk.
			14 January 2021
FCA sets expectations for firms to record communications when working from home
FCA focuses on risks associated with unmonitored communications, including the use of unencrypted apps, such as WhatsApp, for sharing potentially sensitive or confidential information when working from home.
			8 January 2021
News alert: Lockdown and other immigration updates
Further to our last alert of 10 December, we have an update in relation to new travel restrictions announced today, visa applications, changes to the coronavirus guidance and on EU citizens relying on a permanent residence document to naturalise as British citizens.
			22 December 2020
HR calls for clarity on COVID vaccinations - Niki Southern quoted in HR Magazine
Niki Southern, Partner in our Employment Law team, was quoted in HR Magazine and Wired discussing the Covid-19 vaccines.
			4 December 2020
Regulation and Uptake of the COVID-19 Vaccine
The government has now approved the supply of the Pfizer-BioNTech COVID-19 vaccine. The reason they have been able to do this so quickly is because they have taken advantage of the temporary authorisation regime laid out by the Human Medicine Regulations of 2012 and 2020. The 2012 Regulations were updated in 2020 specifically to facilitate the smooth rollout of the COVID-19 vaccine. In the public consultation preceding the introduction of these updated regulations, several respondents raised concerns regarding unlicensed vaccines and immunity from civil liability. In practice, very little is known about these regulations and their application. This article seeks to shed some light on the temporary authorisation regime and suggest a means of alleviating concerns in the context of “vaccine hesitancy”.